May 7, 2021
A new IQVIA report found that biosimilar adoption is more favorable where relative reimbursement to physicians is higher for the biosimilar.
April 20, 2021
Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.

Recent Tweets